Continuous Glucose Monitoring to Detect Postpartum Dysglycemia in Patients With Gestational Diabetes
Starting soon · Not applicable
Conditions studied: Gestational Diabetes
In brief
The aim of this study is to determine the ability of postpartum continuous glucose monitoring (CGM) for subjects with gestational diabetes (GDM) to predict dysglycemia on 4-12 week postpartum oral glucose tolerance test (OGTT).
Key facts
- Study ID
- NCT07034261
- Run by
- University of Chicago
- People needed
- 50
- Starts
- 2026-09-01
- Expected to finish
- 2027-09-01
- Last updated by the study team
- 2026-06-11
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Age greater than or equal to 18
- Completed pregnancy with delivery of a live born infant(s). Pregnancies with multiple gestations will be included
- No prior history of type 1 or type 2 diabetes
- Patients with a history of gestational diabetes (GDM) in a prior pregnancy will be eligible for inclusion.
- GDM diagnosis by standard screening at 24-28 weeks
- 2 hour 75g oral glucose tolerance test (OGTT); one abnormal value required for diagnosis
- Fasting glucose 92
- 1 hour 180
- 2 hour 153
- 3 hour 100g OGTT - two abnormal values required for diagnosis
- Fasting glucose - 95
- 1 hour 180
- 2 hour 155
- 3 hour 140
- There are no exclusion criteria for this study. Eligibility will be based on inclusion criteria.
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.